Evolent Health Prices $159M Secondary Sale Led By Cravath
Evolent Health Inc. has announced that certain shareholders will sell 7.5 million shares through a secondary offering that could net $159.4 million, with the company receiving guidance on the deal from...To view the full article, register now.
Already a subscriber? Click here to view full article